Pricing Log in Create free account

Creative Medical Technology Holdings, Inc. (CELZ) vs Cadrenal Therapeutics, Inc. (CVKD)

Creative Medical Technology Holdings, Inc. and Cadrenal Therapeutics, Inc. are both Biotechnology companies. Creative Medical Technology Holdings, Inc. is the larger, with a market value of $4.0M against $3.6M — 1.1× the size. Across the 10 metrics below, Creative Medical Technology Holdings, Inc. leads on 8 and Cadrenal Therapeutics, Inc. on 2.

Valuation

Metric CELZ CVKD Biotechnology median
P/E n/m n/m 10.60
P/S 135.00 n/m 9.40
P/B 0.26 0.74 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 1.05 n/m 0.66
EV/Sales (377.99) n/m 9.02
Earnings yield (333.87%) (471.15%) (32.88%)
Free cash flow yield (489.01%) (335.44%) (23.13%)

Profitability

Metric CELZ CVKD Biotechnology median
Gross margin 61.18% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (77.91%) (275.16%) (51.96%)
Return on assets (73.30%) (199.59%) (46.06%)
Return on invested capital 0.00% (427.54%) 0.00%

Growth

Metric CELZ CVKD Biotechnology median
Revenue growth (TTM) (79.42%) — 6.76%
EPS growth (last fiscal year) 32.08% 23.94% 29.88%
Revenue growth, 5-year CAGR (48.43%) — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CELZ CVKD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 12.91 3.73 4.97
Net debt to EBITDA 1.20 0.30 1.01

Dividend

Metric CELZ CVKD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CELZ CVKD Biotechnology median
Market cap 4.00m 3.57m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack